Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Ранг среди акций #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Цена акции
$0.00244926
Рыночная капитализация
$51.67K
Изменение (1 день)
5.88%
Изменение (1 год)
110.15%
Страна
GB
Торговля Nuformix plc (NFX)

Категория

EPS для Nuformix plc (NFX)
EPS по состоянию на September 2025 TTM: $0.00
Согласно последним финансовым отчетам и цене акций Nuformix plc, текущий EPS компании (TTM) составляет $0.00. В конце 2024 EPS компании составлял $-0.01, меньше, чем показателю 2023 года, равному $0.00.
История EPS компании Nuformix plc с 2014 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) 0.00 -100.00%
2025 0.00 -100.00%
2024 $-0.01 520.00%
2023 0.00 -60.00%
2022 0.00 -16.67%
2021 0.00 50.00%
2020 0.00 -57.45%
2019 0.00 -31.88%
2018 $-0.01 -23.33%
2017 $-0.01 8.43%
2016 $-0.01 0.00%
2014 0.00 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$3.62 -402,577.78%
DK
$15.47 -1,718,988.89%
US
$43.12 -4,791,211.11%
US
$9.62 -1,069,077.78%
BE
$2.98 -331,211.11%
AU